StonvexLoading…
StonvexStonvexStonvexCore line items from WU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.10B | $948.70M | $3.88B | $2.91B | $1.92B |
Operating Income | Not available | $123.00M | $757.30M | $572.00M | $370.10M |
Net Income | Not available | $64.70M | $499.60M | $385.20M | $245.60M |
EPS (Diluted) | $0.45 | $0.20 | $1.52 | $1.17 | $0.73 |
Total Assets | Not available | $8.10B | $8.31B | $7.78B | $7.98B |
Total Liabilities | Not available | $7.19B | $7.35B | $6.86B | $7.10B |
Cash & Equivalents | Not available | $909.20M | $1.23B | $947.80M | $1.02B |
Free Cash Flow OCF − CapEx | Not available | $102.60M | $505.20M | $389.70M | $137.00M |
Shares Outstanding | Not available | 312.70M | 315.70M | 318.50M | 324.30M |